ALPS Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.24M Sell
3,067
-429
-12% -$174K 0.01% 457
2025
Q1
$1.74M Buy
3,496
+568
+19% +$283K 0.01% 369
2024
Q4
$1.52M Sell
2,928
-29
-1% -$15.1K 0.01% 388
2024
Q3
$1.83M Buy
2,957
+1,744
+144% +$1.08M 0.01% 373
2024
Q2
$671K Sell
1,213
-123
-9% -$68K ﹤0.01% 536
2024
Q1
$776K Buy
1,336
+58
+5% +$33.7K 0.01% 540
2023
Q4
$678K Buy
1,278
+70
+6% +$37.2K 0.01% 562
2023
Q3
$611K Sell
1,208
-1,322
-52% -$669K 0.01% 569
2023
Q2
$1.32M Sell
2,530
-2,620
-51% -$1.37M 0.01% 404
2023
Q1
$2.97M Sell
5,150
-595
-10% -$343K 0.03% 235
2022
Q4
$3.16M Sell
5,745
-477
-8% -$263K 0.03% 226
2022
Q3
$3.16M Sell
6,222
-2,709
-30% -$1.37M 0.03% 215
2022
Q2
$4.85M Buy
8,931
+1,860
+26% +$1.01M 0.05% 179
2022
Q1
$4.18M Sell
7,071
-124
-2% -$73.2K 0.05% 138
2021
Q4
$4.8M Buy
7,195
+99
+1% +$66.1K 0.05% 152
2021
Q3
$4.05M Sell
7,096
-263
-4% -$150K 0.04% 186
2021
Q2
$3.71M Buy
7,359
+970
+15% +$489K 0.03% 195
2021
Q1
$2.92M Buy
6,389
+1,261
+25% +$575K 0.03% 220
2020
Q4
$2.39M Sell
5,128
-197
-4% -$91.7K 0.03% 250
2020
Q3
$2.35M Buy
5,325
+4,646
+684% +$2.05M 0.03% 213
2020
Q2
$246K Sell
679
-78
-10% -$28.3K ﹤0.01% 659
2020
Q1
$215K Sell
757
-5,611
-88% -$1.59M ﹤0.01% 728
2019
Q4
$2.07M Sell
6,368
-255
-4% -$82.9K 0.02% 224
2019
Q3
$1.93M Buy
6,623
+972
+17% +$283K 0.02% 213
2019
Q2
$1.66M Sell
5,651
-1,147
-17% -$337K 0.01% 252
2019
Q1
$1.86M Sell
6,798
-6,577
-49% -$1.8M 0.01% 231
2018
Q4
$2.99M Buy
13,375
+1,831
+16% +$410K 0.02% 191
2018
Q3
$2.82M Buy
+11,544
New +$2.82M 0.02% 211